DOUGLAS RICHARD

Insider Buys Quantity –
16
2023-03-29PurchaseMaxCyte, Inc.
MXCT
director
80,000
0.0762%
$4.32$345,480+1.76%
2021-11-22PurchaseMaxCyte, Inc.
MXCT
director
40,000
0.0463%
$11.12$444,800-43.23%
2020-03-16PurchaseAldeyra Therapeutics, Inc.
ALDX
director
80,000
0.4649%
$2.75$220,000+316.67%
2019-09-13PurchaseAldeyra Therapeutics, Inc.
ALDX
director
10,000
0.0384%
$6.00$60,000-6.94%
2019-09-12PurchaseAldeyra Therapeutics, Inc.
ALDX
director
20,000
0.076%
$6.03$120,552-8.38%
2019-09-11PurchaseAldeyra Therapeutics, Inc.
ALDX
director
20,000
0.0756%
$5.89$117,805-6.78%
2019-09-10PurchaseAldeyra Therapeutics, Inc.
ALDX
director
20,000
0.0672%
$5.09$101,714-3.94%
2019-09-09PurchaseAldeyra Therapeutics, Inc.
ALDX
director
20,000
0.0752%
$5.00$99,963+9.39%
2017-05-11PurchaseNovavax, Inc.
NVAX
director
400,000
0.1416%
$0.93$371,560+27.96%
2017-02-17PurchaseAldeyra Therapeutics, Inc.
ALDX
director
80,000
0.5116%
$4.50$360,000+0.98%
2016-09-21PurchaseNovavax, Inc.
NVAX
director
200,000
0.0654%
$1.72$344,020-34.54%
2014-03-25PurchaseNovavax, Inc.
NVAX
director
100,000
0.0463%
$4.33$433,400+6.81%
2013-06-12PurchaseNovavax, Inc.
NVAX
director
100,000
0.0653%
$1.90$190,000+104.97%
2012-04-10PurchaseNovavax, Inc.
NVAX
director
100,000
0.0815%
$1.21$121,000+62.39%
2011-08-09PurchaseNovavax, Inc.
NVAX
director
100,000
0.0761%
$1.20$120,000+0.73%
2011-06-20PurchaseNovavax, Inc.
NVAX
director
100,000
0.0911%
$2.04$203,500-30.3%
Stocks ScreenerTop-50 StocksInsiders ScreenerList of All Stocks
About Prismo.proPrivacy PolicyTerms of ServiceContact Us